STAT6 and acute respiratory distress syndrome: This study suggests that BMSCs‐Exos regulate the TRIM24/CBP/STAT6 axis via miR‐137‐3p delivery and targeting the TRIM24‐STAT6 acetylation pathway may provide a promising therapeutic strategy for ALI.